Article
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus.
Lupus - 1 May 2023
Chung Cecilia P, Karakoc Gul, Dickson Alyson, Liu Ge, Gamboa Jorge L, Mosley Jonathan D, Cox Nancy J, Kawai Vivian K
Abstract excerpt
BACKGROUND: Systemic lupus erythematosus (SLE) disproportionately affects individuals of African ancestry (AA) compared to European ancestry (EA). In the general population, high risk (HR) variants in the apolipoprotein L1 (APOL1) gene increase the risk of renal and hypertensive disorders in individuals of AA. Since SLE is characterized by an interferon signature and APOL1 expression is driven by interferon, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
